Brief: GE Healthcare To Acquire Sofie Biosciences, Establishing A 'Final Mile' Footprint For Pet Radiopharmaceutical Supply In The U.S.
BRIEF-GE Healthcare To Acquire Sofie Biosciences, Establishing A 'Final Mile' Footprint For Pet Radiopharmaceutical Supply In The U.S. GE HealthCare Technologies Inc. GEHC.O:
GE HEALTHCARE TO ACQUIRE SOFIE BIOSCIENCES, ESTABLISHING A 'FINAL MILE' FOOTPRINT FOR PET RADIOPHARMACEUTICAL SUPPLY IN THE U.S.
GE HEALTHCARE - TO BUY SOFIE BIOSCIENCES FOR $945 MILLION IN CASH
GE HEALTHCARE TO ACQUIRE SOFIE BIOSCIENCES, ESTABLISHING A 'FINAL MILE' FOOTPRINT FOR PET RADIOPHARMACEUTICAL SUPPLY IN THE U.S.
GE HEALTHCARE - DEAL EXPECTED TO BE ACCRETIVE TO ADJUSTED EBIT MARGIN AND ADJUSTED EPS IN FIRST YEAR
GE HEALTHCARE: SOFIE BIOSCIENCES WILL CONTINUE TO OPERATE AS AN INDEPENDENT MANUFACTURING PARTNER TO ITS CUSTOMERS
Source text: ID:nBw19N8Mma
Further company coverage: GEHC.O
Recent news on GE HealthCare Technologies
See all newsBrief: GE Healthcare Expands General Imaging Ultrasound Portfolio With Logiq Focus
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
GE HealthCare slip after $945 million deal for Sofie Biosciences